Navigation Links
GeNO LLC Initiates Study of Inhaled NITROSYL™ Nitric Oxide in Idiopathic Pulmonary Fibrosis (PH-IPF) and Pulmonary Arterial Hypertension (PAH) Patients
Date:3/22/2011

second cartridge is provided for redundancy.  

"Results from this study will provide information necessary to design a Phase 2/3 study for chronic ambulatory administration of nitric oxide," said GeNO LLC Founder and President David Fine, Ph.D.  "The combined results from this current Phase 2 study and planned Phase 2/3 chronic study will help to define responses in both populations and further guide Phase 3 development."

"Our Phase 2 program will assess whether nitric oxide improves pulmonary hypertension in both populations, whether there are safety concerns in either group that are unique to that condition (or background treatment) or shared by both, and whether the profile of effect is common," added GeNO Vice President Robert F. Roscigno, Ph.D.  "While IPF and PAH are different, GeNO will focus on the one common feature, the pulmonary hypertension, which is a determinant of survival and at least an element or cause of symptoms."

No medications are currently approved for treatment of pulmonary hypertension (PH) associated with idiopathic pulmonary fibrosis (IPF).  IPF is characterized by progressive fibrosis in the lungs with a median survival time from diagnosis of two to five years and a five-year survival rate of approximately 20 percent.  Pulmonary arterial hypertension (PAH) is a rare progressive disorder that carries a poor prognosis and is associated with significant morbidity and mortality, having an historical survival rate rarely exceeding five years.  

The next version of GeNO's platform to enter the clinic later this year will be the GeNO Ambulatory NITROSYL™ System, which is a hand-held unit with a disposable liquid source.  This portable unit snaps into a small, battery operated pump module attaching to a hip or arm holster and provides up to a 4-day continuous supply of inhaled nitric oxide for chronic use.

In December 2010, GeNO initiated its first clinical study, a 1
'/>"/>

SOURCE GeNO LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
2. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
6. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
7. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. Prolexys Pharmaceuticals Initiates Phase 1 Study
10. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
11. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Mass. , Sept. 16, 2014  Decision Resources Group finds ... from $14 billion in 2013 to over $18.2 billion in 2023 ... , Germany , Italy ... and Japan . TNF-alpha inhibitors will ... in the RA market, but growth will be constrained and patient ...
(Date:9/16/2014)... 16, 2014 Surgeons at The Children,s Hospital ... case report the first successful use of a SynCardia ... boy with failing Fontan circulation to bridge him to ... years old, the patient received a Fontan circulation procedure ... ventricle. "The Fontan operation is the final planned palliative ...
(Date:9/16/2014)... 16, 2014  Formex, LLC ("Formex"), a ... Mr. Greg Weilersbacher joined Formex as Director of ... Greg Weilersbacher has over ... expertise in Quality Assurance, Facility Validation, GMP ... brings to Formex a diverse wealth of ...
Breaking Medicine Technology:The Rheumatoid Arthritis Drug Market Will Grow to $18.2 Billion in 2023, Driven by the Uptake of Oral Jak Inhibitors and Non TNF-alpha Biologics 2The Rheumatoid Arthritis Drug Market Will Grow to $18.2 Billion in 2023, Driven by the Uptake of Oral Jak Inhibitors and Non TNF-alpha Biologics 313-Year-Old Boy with Failed Fontan Circulation Bridged to Transplant Using the SynCardia Total Artificial Heart, Published in Annals of Thoracic Surgery 213-Year-Old Boy with Failed Fontan Circulation Bridged to Transplant Using the SynCardia Total Artificial Heart, Published in Annals of Thoracic Surgery 3Greg Weilersbacher Joins Formex, LLC As Director of Quality Assurance and Quality Control 2
... and KOS, Greece, June 29, 2007 /PRNewswire/ --,The ... treated patients on REVLIMID (lenalidomide) plus the,steroid dexamethasone ... The data are pooled from two large randomized,controlled ... patients,from nearly 100 clinical sites worldwide. These updated ...
... at the 11th International Myeloma Workshop ... of perifosine in,combination with bortezomib, dexamethasone ... relapsed/refractory multiple,myeloma, and as a single ... NEW YORK, June 29, 2007 /PRNewswire-FirstCall/ ...
Cached Medicine Technology:The European Myeloma Platform Reports New Survival data for,Revlimid Presented at the International Myeloma Workshop in Greece 2Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 2Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 3Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 4Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 5Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 6Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 7
(Date:9/16/2014)... 16, 2014 Definitive Healthcare ... and healthcare providers, is pleased to announce the ... online database, now available for subscription, features detailed ... health system affiliations. , The Canadian database spans ... intelligence on over 750 hospitals. Each hospital ...
(Date:9/16/2014)... An experimental positron emission tomography (PET) ... a person is still alive, according to a case ... Mount Sinai, and at Molecular Neuroimaging (MNI) LLC in ... Translational Psychiatry. , Specifically, the study results suggest that ... designed to latch onto a protein called tau that ...
(Date:9/16/2014)... Terminsurancevirginia.com has released a new blog ... life insurance for obese clients. , Obese clients ... quotes. It is unlikely for applicants to be denied ... life insurance costs. , Having life insurance is ... Life insurance is available as temporary or permanent coverage ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 Gary F. ... of China, has selected Worldwide Speakers Group for exclusive ... U.S. Secretary of Commerce and Governor of Washington, Locke ... authorities on U.S.-China relations, global expansion, and business growth. ... global competitiveness and how to grow an organization’s global ...
(Date:9/16/2014)... 2014 Representatives with safetyBUILT-IN ( ... the first phase of a safety-culture-development initiative for ... York, and just recently launched Phase II of ... now the third such facility where safetyBUILT-IN has ... safetyBUILT-IN Principal Eric Svendsen, Ph.D. “The first two ...
Breaking Medicine News(10 mins):Health News:Canadian Hospital Database Now Offered by Definitive Healthcare 2Health News:Neuroimaging Technique Identifies Concussion-Related Brain Disease in Living Brain 2Health News:Neuroimaging Technique Identifies Concussion-Related Brain Disease in Living Brain 3Health News:Neuroimaging Technique Identifies Concussion-Related Brain Disease in Living Brain 4Health News:Obese Clients Can Find Affordable No Exam Term Life Insurance at Terminsurancevirginia.com! 2Health News:Gary Locke, Former Ambassador to China, Selects Worldwide Speakers Group for Exclusive Lecture Representation 2Health News:safetyBUILT-IN Leads Safety-Culture Field-Coaching Effort 2
... a virtually eradicated disease that eats through people's skin, ... South America. ,WHO reported that it ... the skin and bone wasting disease Yaws. The disease ... a bacterial infection, can cause debilitating deformations, particularly in ...
... local and international experts, vaulting over a buffer between ... Central province, for the first time. This has created ... Nairobi. ,The buffer was created by the ... Organisation (WHO) and Food and Agricultural Organisation (FAO). ...
... risk of catching bird flu, as the deadly virus is most ... on cats in areas where outbreaks have occurred found that the ... the chilling prospect that the disease could soon easily be spread ... shows that should bird flu ever break out in Britain, cat ...
... predict disease outbreaks may want to tune into more weather ... finding out when an epidemic is imminent because they determine ... ,The techniques can help quicken the response to ... heat wave and global warming is adding urgency to such ...
... of Informatics-led team of researchers has constructed a model ... across the globe// by airliners. ,The study, ... and Containment Intervention," appears in the January issue of ... said to be the world's largest-scale epidemic simulation of ...
... A new study suggests that TEMPE, a topical anesthetic ... treatment for men with premature ejaculation and might be ... study is published in the February issue of the ... UK and Netherlands studied 54 men with premature ejaculation, ...
Cached Medicine News:Health News:Kenya: Alert As Virus Leaps Over Buffer Zone 2Health News:Kenya: Alert As Virus Leaps Over Buffer Zone 3Health News:Cat Owners at Risk of Bird Flu 2Health News:Experts Use Weather to Predict Disease 2Health News:Scientists Assess Risk of Flu Pandemic Spread Via Global Airlines 2Health News:Scientists Assess Risk of Flu Pandemic Spread Via Global Airlines 3Health News:TEMPE Spray Delays Ejaculation 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: